(2020). Avelumab/pembrolizumab: COVID-19 infection and recurrent infusion reactions: case report. Reactions Weekly.
Citação norma Chicago"Avelumab/pembrolizumab: COVID-19 Infection and Recurrent Infusion Reactions: Case Report." Reactions Weekly 2020.
MLA Citation"Avelumab/pembrolizumab: COVID-19 Infection and Recurrent Infusion Reactions: Case Report." Reactions Weekly 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.